Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / articles / TECH - Elon Musk's Neuralink Rival Paradromics Gears Up For Human Trials Of Brain Implant | Benzinga


TECH - Elon Musk's Neuralink Rival Paradromics Gears Up For Human Trials Of Brain Implant | Benzinga

Neurotech startup Paradromics is gearing up to conduct human trials of its brain implant in the coming year, marking its entry into the competitive brain-computer interface (BCI) market where Elon Musk’s Neuralink is dominating the headlines.

What Happened: Paradromics’ upcoming trial follows a similar procedure carried out by its competitor, Neuralink, earlier this year, CNBC reported on Friday. The brain implant developed by Paradromics aims to interact with multiple neurons at once, facilitating high-speed, high-data-rate communication.

Paradromics has managed to secure $87 million in venture investment and $18 million in public funding since its establishment in 2015. The Austin-based startup anticipates the devices to ...

Full story available on Benzinga.com

Stock Information

Company Name: Bio-Techne Corp
Stock Symbol: TECH
Market: NASDAQ
Website: bio-techne.com

Menu

TECH TECH Quote TECH Short TECH News TECH Articles TECH Message Board
Get TECH Alerts

News, Short Squeeze, Breakout and More Instantly...